4th Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Period 4th Quarter 2008 Filed Jan 9, 2009 Signed by Cristin Lis

Official filing
Firm
GILEAD SCIENCES, INC.
Client
GILEAD SCIENCES INC
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

International Trade Issues; Global Health Issues; FDA Globalization Act; Domestic HIV Policy Issues (eg. H.R. 1943-Stop AIDS in Prison Act; H.R. 822 - Routine HIV/AIDS Screening Coverage Act; H.R. 6114, S 2969 - Simplifying and Updating National Standards to Encourage Testing of the HIV Act; Ryan White Program Reauthorization Act)

LobbyistCovered position, as disclosed
CRISTIN LIS —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 822 (110th), H.R. 6114 (110th), H.R. 1943 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.